Release Date: 13/07/15 12:03 Summary: Net Tangible Asset Backing Price Sensitive: No Download Document 157.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%